“Marching-in” on Patent Rights: The Biden Administration’s Effort to Lower Pharmaceutical Prices April 14, 2024 | By Ancheng Da On December 7, 2023, the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) issued a notice-and-comment period for their new Read More Patents pharmaceutical drugs NIST regulation Bayh-Dole Act
